533138 Stock Overview
Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemical active ingredients and pharmaceutical intermediates in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Astec LifeSciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,263.70 |
| 52 Week High | ₹1,540.00 |
| 52 Week Low | ₹826.15 |
| Beta | 0.34 |
| 1 Month Change | 12.53% |
| 3 Month Change | 26.65% |
| 1 Year Change | -5.33% |
| 3 Year Change | 10.53% |
| 5 Year Change | 147.83% |
| Change since IPO | 1,406.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| 533138 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 0.6% | 1.9% | 1.4% |
| 1Y | -5.3% | 18.9% | 46.1% |
Return vs Industry: 533138 underperformed the Indian Chemicals industry which returned 18.9% over the past year.
Return vs Market: 533138 underperformed the Indian Market which returned 46.1% over the past year.
Price Volatility
| 533138 volatility | |
|---|---|
| 533138 Average Weekly Movement | 7.0% |
| Chemicals Industry Average Movement | 6.5% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 533138's share price has been volatile over the past 3 months.
Volatility Over Time: 533138's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 551 | Anurag Roy | www.astecls.com |
Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemical active ingredients and pharmaceutical intermediates in India. Its products include triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic, aliphatic, and heterocyclic intermediates; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; heterocyclic mercaptans, thiopyrimidines, and aromatic mercaptans; heterocyclic sulfonyl chlorides, sulphonamides, and carbamates; thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company’s products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols.
Astec LifeSciences Limited Fundamentals Summary
| 533138 fundamental statistics | |
|---|---|
| Market cap | ₹24.77b |
| Earnings (TTM) | -₹509.39m |
| Revenue (TTM) | ₹4.32b |
5.7x
P/S Ratio-48.6x
P/E RatioIs 533138 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 533138 income statement (TTM) | |
|---|---|
| Revenue | ₹4.32b |
| Cost of Revenue | ₹3.06b |
| Gross Profit | ₹1.26b |
| Other Expenses | ₹1.77b |
| Earnings | -₹509.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -25.98 |
| Gross Margin | 29.16% |
| Net Profit Margin | -11.80% |
| Debt/Equity Ratio | 109.2% |
How did 533138 perform over the long term?
See historical performance and comparison